关于米勒帕辛及其衍生品作为潜在的多目标抗癌剂的审查
Shailima Rampogu1, Pallavi Badvel2, Byung Hoon Jo3
1Department of Bio & Medical Big Data (BK4 Program), Division of Life Sciences, Research Institute of Natural Science (RINS), Gyeongsang National University (GNU), 501 Jinju-daero, Jinju, 52828, South Korea.
Biochemical and biophysical research communications
|October 4, 2023
概括
米勒帕辛及其衍生物显示出作为抗癌剂的显著潜力,通过抑制蛋白聚合并诱导亡,有效向各种癌症. 需要进一步的临床研究来证实这些有希望的临床前发现,用于癌症治疗的发展.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 哈尔科纳被认为是药物化学中的特权支架,具有治疗应用的历史.
- 米勒帕辛及其衍生品代表了一类化合物,具有针对各种恶性瘤的证明潜力.
研究的目的:
- 审查米勒帕辛及其衍生物在一系列癌症中的抗癌作用.
- 阐明其治疗潜力的基础上的分子机制.
主要方法:
- 关于米勒帕辛及其衍生物的临床前研究的文献综述.
- 分析它们对基因表达和与癌症相关的细胞过程的影响.
主要成果:
- 米勒帕辛衍生物在卵巢癌,肝细胞癌,乳腺,肝脏,结肠,宫,前列腺,胃和质瘤中表现出抗癌活性.
- 这些化合物主要通过抑制蛋白聚合而起作用,从而导致细胞亡和细胞循环在G2/M阶段停止.
- 已证明抑制癌细胞入侵和迁移,并具有显著的抗增殖作用.
结论:
- 米勒帕辛及其衍生物具有相当大的临床前抗癌潜力.
- 通过临床试验进行确认对于开发基于这些化合物的新型癌症疗法至关重要.
相关概念视频
Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...


